ImmunoPrecise Antibodies Statistics
Total Valuation
IPA has a market cap or net worth of $16.53 million. The enterprise value is $25.78 million.
Important Dates
The next estimated earnings date is Thursday, March 13, 2025, before market open.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IPA has 33.53 million shares outstanding. The number of shares has increased by 7.62% in one year.
| Current Share Class | 33.53M |
| Shares Outstanding | 33.53M |
| Shares Change (YoY) | +7.62% |
| Shares Change (QoQ) | +3.68% |
| Owned by Insiders (%) | 12.64% |
| Owned by Institutions (%) | 5.66% |
| Float | 29.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| Forward PS | 0.55 |
| PB Ratio | 0.68 |
| P/TBV Ratio | 13.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.01 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -114.12 |
Financial Efficiency
Return on equity (ROE) is -65.88% and return on invested capital (ROIC) is -16.75%.
| Return on Equity (ROE) | -65.88% |
| Return on Assets (ROA) | -13.68% |
| Return on Capital (ROIC) | -16.75% |
| Revenue Per Employee | $171,013 |
| Profits Per Employee | -$198,247 |
| Employee Count | 101 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 5.37 |
Taxes
| Income Tax | -1.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.69% in the last 52 weeks. The beta is 0.19, so IPA's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -66.69% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 52.66 |
| Average Volume (20 Days) | 409,300 |
Short Selling Information
The latest short interest is 103,639, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 103,639 |
| Short Previous Month | 149,965 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 0.70 |
Income Statement
In the last 12 months, IPA had revenue of $17.27 million and -$20.02 million in losses. Loss per share was -$0.74.
| Revenue | 17.27M |
| Gross Profit | 8.68M |
| Operating Income | -10.65M |
| Pretax Income | -20.89M |
| Net Income | -20.02M |
| EBITDA | -8.73M |
| EBIT | -10.65M |
| Loss Per Share | -$0.74 |
Full Income StatementBalance Sheet
The company has $2.54 million in cash and $11.79 million in debt, giving a net cash position of -$9.25 million or -$0.28 per share.
| Cash & Cash Equivalents | 2.54M |
| Total Debt | 11.79M |
| Net Cash | -9.25M |
| Net Cash Per Share | -$0.28 |
| Equity (Book Value) | 23.45M |
| Book Value Per Share | 0.77 |
| Working Capital | 66,738 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.56 million and capital expenditures -$925,727, giving a free cash flow of -$6.30 million.
| Operating Cash Flow | -5.56M |
| Capital Expenditures | -925,727 |
| Free Cash Flow | -6.30M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
Gross margin is 50.27%, with operating and profit margins of -61.64% and -115.93%.
| Gross Margin | 50.27% |
| Operating Margin | -61.64% |
| Pretax Margin | -125.11% |
| Profit Margin | -115.93% |
| EBITDA Margin | -50.56% |
| EBIT Margin | -61.64% |
| FCF Margin | n/a |
Dividends & Yields
IPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.62% |
| Shareholder Yield | -7.62% |
| Earnings Yield | -121.12% |
| FCF Yield | -38.11% |
Analyst Forecast
The average price target for IPA is $5.00, which is 914.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 914.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 15.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 23, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Nov 23, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
IPA has an Altman Z-Score of -1.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.92 |
| Piotroski F-Score | 2 |